Cargando…
Molecular basis of differential 3′ splice site sensitivity to anti-tumor drugs targeting U2 snRNP
Several splicing-modulating compounds, including Sudemycins and Spliceostatin A, display anti-tumor properties. Combining transcriptome, bioinformatic and mutagenesis analyses, we delineate sequence determinants of the differential sensitivity of 3′ splice sites to these drugs. Sequences 5′ from the...
Autores principales: | Vigevani, Luisa, Gohr, André, Webb, Thomas, Irimia, Manuel, Valcárcel, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727392/ https://www.ncbi.nlm.nih.gov/pubmed/29235465 http://dx.doi.org/10.1038/s41467-017-02007-z |
Ejemplares similares
-
Structure of the spliceosomal U4 snRNP core domain and its implication for snRNP biogenesis
por: Leung, Adelaine K. W., et al.
Publicado: (2011) -
TSSC4 is a component of U5 snRNP that promotes tri-snRNP formation
por: Klimešová, Klára, et al.
Publicado: (2021) -
The Hunting of the snRNP
por: Leslie, Mitch
Publicado: (2006) -
Multi-step recognition of potential 5' splice sites by the Saccharomyces cerevisiae U1 snRNP
por: Hansen, Sarah R, et al.
Publicado: (2022) -
Structural basis of intron selection by U2 snRNP in the presence of covalent inhibitors
por: Cretu, Constantin, et al.
Publicado: (2021)